Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ia/Ib study of the P27A malaria vaccine candidate
PACTR201310000683408Phase 1Unknown
- Sponsor
- Lausanne University Hospital
- Start
- Jan 2014
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 1 trial of P27A and Rabies vaccine in malaria (7 arms), sponsored by Lausanne University Hospital. Primary endpoints: Safety and Immediate local and systemic reactogenicity. Status: unknown.
02
Drugs
P27ARabies vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201310000683408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201310000683408.